SCHEMBL2114879

SCHEMBL2114879

CC(C)OC(=O)CN(C)C(=O)C(C)OC(=O)C=CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 8/20 0.54
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2114877 1.00 HCAR2 (0.54) HCAR2TSHR
SCHEMBL19760891 0.88 HCAR2 (0.39) HCAR2
SCHEMBL2115866 0.86 HCAR2 (0.47) HCAR2
SCHEMBL2115869 0.86 HCAR2 (0.47) HCAR2
SCHEMBL2114294 0.78 HCAR2 (0.49) HCAR2TSHR
SCHEMBL2114299 0.78 HCAR2 (0.49) HCAR2TSHR
SCHEMBL2115986 0.77 HCAR2 (0.59) HCAR2TSHR
SCHEMBL2115988 0.77 HCAR2 (0.59) HCAR2TSHR
SCHEMBL2114878 0.77 HCAR2 (0.40) HCAR2
SCHEMBL2609722 0.74 CA12 (0.43) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095003-A1 METHODS OF USING PRODRUGS OF METHYL HYDROGEN FUMARATE AND PHARMACEUTICAL COMPOSITIONS THEREOF XENOPORT, INC. (US) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095003-A1 METHODS OF USING PRODRUGS OF METHYL HYDROGEN FUMARATE AND PHARMACEUTICAL COMPOSITIONS THEREOF FH, MGMT, BHMT2 HCAR2 68/4885TSHR 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.